• レポートコード:GIR201100447 • 出版社/出版日:GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、131ページ • 納品方法:Eメール • 産業分類:医薬品・医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、アルコール依存症治療の世界市場を調査対象にし、アルコール依存症治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他)、用途別分析(病院、クリニック、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報:AstraZeneca Plc、Eli Lilly and Company、Cerecor Inc、BioCorRx Inc、Curemark LLC、Bionex Pharmaceuticals LLC、H. Lundbeck A/S、Corcept Therapeutics Inc、Chronos Therapeutics Ltd、Ethypharm SA、Lohocla Research Corp、Opiant Pharmaceuticals Inc、Heptares Therapeutics Ltd、Montisera Ltd、Kyorin Pharmaceutical Co Ltd、Indivior Plc、Omeros Corp、Kinnov Therapeutics SAS ・メーカー別販売量、売上、市場シェア ・アルコール依存症治療の地域別市場分析 ・アルコール依存症治療の北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・アルコール依存症治療のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・アルコール依存症治療のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・アルコール依存症治療の南米市場規模2015-2020:ブラジル、アルゼンチンなど ・アルコール依存症治療の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・アルコール依存症治療の種類別市場規模2015-2020:CM-1212、CTDP-002、A-705253、ABT-436、ADX-71441、その他 ・アルコール依存症治療の用途別市場規模2015-2020:病院、クリニック、その他 ・アルコール依存症治療の世界市場予測2021-2025:地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Alcohol Addiction Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Alcohol Addiction Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alcohol Addiction Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alcohol Addiction Therapeutics market has been segmented into
CM-1212
CTDP-002
A-705253
ABT-436
ADX-71441
Others
By Application, Alcohol Addiction Therapeutics has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alcohol Addiction Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Alcohol Addiction Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alcohol Addiction Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Alcohol Addiction Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Alcohol Addiction Therapeutics Market Share Analysis
Alcohol Addiction Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alcohol Addiction Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alcohol Addiction Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Alcohol Addiction Therapeutics are:
AstraZeneca Plc
Eli Lilly and Company
Cerecor Inc
BioCorRx Inc
Curemark LLC
Bionex Pharmaceuticals LLC
H. Lundbeck A/S
Corcept Therapeutics Inc
Chronos Therapeutics Ltd
Ethypharm SA
Lohocla Research Corp
Opiant Pharmaceuticals Inc
Heptares Therapeutics Ltd
Montisera Ltd
Kyorin Pharmaceutical Co Ltd
Indivior Plc
Omeros Corp
Kinnov Therapeutics SAS
Among other players domestic and global, Alcohol Addiction Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alcohol Addiction Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alcohol Addiction Therapeutics, with price, sales, revenue and global market share of Alcohol Addiction Therapeutics in 2018 and 2019.
Chapter 3, the Alcohol Addiction Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alcohol Addiction Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Alcohol Addiction Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Alcohol Addiction Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Alcohol Addiction Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alcohol Addiction Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CM-1212
1.2.3 CTDP-002
1.2.4 A-705253
1.2.5 ABT-436
1.2.6 ADX-71441
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Alcohol Addiction Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Alcohol Addiction Therapeutics Market
1.4.1 Global Alcohol Addiction Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company SWOT Analysis
2.2.4 Eli Lilly and Company Product and Services
2.2.5 Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cerecor Inc
2.3.1 Cerecor Inc Details
2.3.2 Cerecor Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cerecor Inc SWOT Analysis
2.3.4 Cerecor Inc Product and Services
2.3.5 Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioCorRx Inc
2.4.1 BioCorRx Inc Details
2.4.2 BioCorRx Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioCorRx Inc SWOT Analysis
2.4.4 BioCorRx Inc Product and Services
2.4.5 BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Curemark LLC
2.5.1 Curemark LLC Details
2.5.2 Curemark LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Curemark LLC SWOT Analysis
2.5.4 Curemark LLC Product and Services
2.5.5 Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bionex Pharmaceuticals LLC
2.6.1 Bionex Pharmaceuticals LLC Details
2.6.2 Bionex Pharmaceuticals LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bionex Pharmaceuticals LLC SWOT Analysis
2.6.4 Bionex Pharmaceuticals LLC Product and Services
2.6.5 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 H. Lundbeck A/S
2.7.1 H. Lundbeck A/S Details
2.7.2 H. Lundbeck A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 H. Lundbeck A/S SWOT Analysis
2.7.4 H. Lundbeck A/S Product and Services
2.7.5 H. Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Corcept Therapeutics Inc
2.8.1 Corcept Therapeutics Inc Details
2.8.2 Corcept Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Corcept Therapeutics Inc SWOT Analysis
2.8.4 Corcept Therapeutics Inc Product and Services
2.8.5 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Chronos Therapeutics Ltd
2.9.1 Chronos Therapeutics Ltd Details
2.9.2 Chronos Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Chronos Therapeutics Ltd SWOT Analysis
2.9.4 Chronos Therapeutics Ltd Product and Services
2.9.5 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethypharm SA
2.10.1 Ethypharm SA Details
2.10.2 Ethypharm SA Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ethypharm SA SWOT Analysis
2.10.4 Ethypharm SA Product and Services
2.10.5 Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lohocla Research Corp
2.11.1 Lohocla Research Corp Details
2.11.2 Lohocla Research Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Lohocla Research Corp SWOT Analysis
2.11.4 Lohocla Research Corp Product and Services
2.11.5 Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Opiant Pharmaceuticals Inc
2.12.1 Opiant Pharmaceuticals Inc Details
2.12.2 Opiant Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Opiant Pharmaceuticals Inc SWOT Analysis
2.12.4 Opiant Pharmaceuticals Inc Product and Services
2.12.5 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Heptares Therapeutics Ltd
2.13.1 Heptares Therapeutics Ltd Details
2.13.2 Heptares Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Heptares Therapeutics Ltd SWOT Analysis
2.13.4 Heptares Therapeutics Ltd Product and Services
2.13.5 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Montisera Ltd
2.14.1 Montisera Ltd Details
2.14.2 Montisera Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Montisera Ltd SWOT Analysis
2.14.4 Montisera Ltd Product and Services
2.14.5 Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Kyorin Pharmaceutical Co Ltd
2.15.1 Kyorin Pharmaceutical Co Ltd Details
2.15.2 Kyorin Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Kyorin Pharmaceutical Co Ltd SWOT Analysis
2.15.4 Kyorin Pharmaceutical Co Ltd Product and Services
2.15.5 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Indivior Plc
2.16.1 Indivior Plc Details
2.16.2 Indivior Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Indivior Plc SWOT Analysis
2.16.4 Indivior Plc Product and Services
2.16.5 Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Omeros Corp
2.17.1 Omeros Corp Details
2.17.2 Omeros Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Omeros Corp SWOT Analysis
2.17.4 Omeros Corp Product and Services
2.17.5 Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Kinnov Therapeutics SAS
2.18.1 Kinnov Therapeutics SAS Details
2.18.2 Kinnov Therapeutics SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Kinnov Therapeutics SAS SWOT Analysis
2.18.4 Kinnov Therapeutics SAS Product and Services
2.18.5 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Alcohol Addiction Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Alcohol Addiction Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Alcohol Addiction Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 Alcohol Addiction Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Alcohol Addiction Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Alcohol Addiction Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Alcohol Addiction Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America Alcohol Addiction Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Alcohol Addiction Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Alcohol Addiction Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
6.4 France Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Alcohol Addiction Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Alcohol Addiction Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7.5 India Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Alcohol Addiction Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America Alcohol Addiction Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Alcohol Addiction Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Alcohol Addiction Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Alcohol Addiction Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Alcohol Addiction Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global Alcohol Addiction Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global Alcohol Addiction Therapeutics Price by Type (2015-2020)
11 Global Alcohol Addiction Therapeutics Market Segment by Application
11.1 Global Alcohol Addiction Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global Alcohol Addiction Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Alcohol Addiction Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 Alcohol Addiction Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America Alcohol Addiction Therapeutics Market Forecast (2021-2025)
12.2.2 Europe Alcohol Addiction Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Alcohol Addiction Therapeutics Market Forecast (2021-2025)
12.2.4 South America Alcohol Addiction Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Alcohol Addiction Therapeutics Market Forecast (2021-2025)
12.3 Alcohol Addiction Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global Alcohol Addiction Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global Alcohol Addiction Therapeutics Market Share Forecast by Type (2021-2025)
12.4 Alcohol Addiction Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global Alcohol Addiction Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global Alcohol Addiction Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Alcohol Addiction Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alcohol Addiction Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alcohol Addiction Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Alcohol Addiction Therapeutics Major Business
Table 9. AstraZeneca Plc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc Alcohol Addiction Therapeutics Product and Services
Table 12. AstraZeneca Plc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly and Company Alcohol Addiction Therapeutics Major Business
Table 15. Eli Lilly and Company Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly and Company SWOT Analysis
Table 17. Eli Lilly and Company Alcohol Addiction Therapeutics Product and Services
Table 18. Eli Lilly and Company Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Cerecor Inc Basic Information, Manufacturing Base and Competitors
Table 20. Cerecor Inc Alcohol Addiction Therapeutics Major Business
Table 21. Cerecor Inc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 22. Cerecor Inc SWOT Analysis
Table 23. Cerecor Inc Alcohol Addiction Therapeutics Product and Services
Table 24. Cerecor Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BioCorRx Inc Basic Information, Manufacturing Base and Competitors
Table 26. BioCorRx Inc Alcohol Addiction Therapeutics Major Business
Table 27. BioCorRx Inc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 28. BioCorRx Inc SWOT Analysis
Table 29. BioCorRx Inc Alcohol Addiction Therapeutics Product and Services
Table 30. BioCorRx Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Curemark LLC Basic Information, Manufacturing Base and Competitors
Table 32. Curemark LLC Alcohol Addiction Therapeutics Major Business
Table 33. Curemark LLC Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 34. Curemark LLC SWOT Analysis
Table 35. Curemark LLC Alcohol Addiction Therapeutics Product and Services
Table 36. Curemark LLC Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bionex Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table 38. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Major Business
Table 39. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 40. Bionex Pharmaceuticals LLC SWOT Analysis
Table 41. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Services
Table 42. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 44. H. Lundbeck A/S Alcohol Addiction Therapeutics Major Business
Table 45. H. Lundbeck A/S Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 46. H. Lundbeck A/S SWOT Analysis
Table 47. H. Lundbeck A/S Alcohol Addiction Therapeutics Product and Services
Table 48. H. Lundbeck A/S Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Corcept Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 50. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Major Business
Table 51. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 52. Corcept Therapeutics Inc SWOT Analysis
Table 53. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Services
Table 54. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Chronos Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Major Business
Table 57. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 58. Chronos Therapeutics Ltd SWOT Analysis
Table 59. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Services
Table 60. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ethypharm SA Basic Information, Manufacturing Base and Competitors
Table 62. Ethypharm SA Alcohol Addiction Therapeutics Major Business
Table 63. Ethypharm SA Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 64. Ethypharm SA SWOT Analysis
Table 65. Ethypharm SA Alcohol Addiction Therapeutics Product and Services
Table 66. Ethypharm SA Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Lohocla Research Corp Basic Information, Manufacturing Base and Competitors
Table 68. Lohocla Research Corp Alcohol Addiction Therapeutics Major Business
Table 69. Lohocla Research Corp Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 70. Lohocla Research Corp SWOT Analysis
Table 71. Lohocla Research Corp Alcohol Addiction Therapeutics Product and Services
Table 72. Lohocla Research Corp Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Opiant Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Major Business
Table 75. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 76. Opiant Pharmaceuticals Inc SWOT Analysis
Table 77. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Services
Table 78. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Heptares Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 80. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Major Business
Table 81. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 82. Heptares Therapeutics Ltd SWOT Analysis
Table 83. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Services
Table 84. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Montisera Ltd Basic Information, Manufacturing Base and Competitors
Table 86. Montisera Ltd Alcohol Addiction Therapeutics Major Business
Table 87. Montisera Ltd Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 88. Montisera Ltd SWOT Analysis
Table 89. Montisera Ltd Alcohol Addiction Therapeutics Product and Services
Table 90. Montisera Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Kyorin Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Major Business
Table 93. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 94. Kyorin Pharmaceutical Co Ltd SWOT Analysis
Table 95. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Services
Table 96. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Indivior Plc Basic Information, Manufacturing Base and Competitors
Table 98. Indivior Plc Alcohol Addiction Therapeutics Major Business
Table 99. Indivior Plc Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 100. Indivior Plc SWOT Analysis
Table 101. Indivior Plc Alcohol Addiction Therapeutics Product and Services
Table 102. Indivior Plc Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Omeros Corp Basic Information, Manufacturing Base and Competitors
Table 104. Omeros Corp Alcohol Addiction Therapeutics Major Business
Table 105. Omeros Corp Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 106. Omeros Corp SWOT Analysis
Table 107. Omeros Corp Alcohol Addiction Therapeutics Product and Services
Table 108. Omeros Corp Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Type and Application
Table 110. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Major Business
Table 111. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Total Revenue (USD Million) (2018-2019)
Table 112. Kinnov Therapeutics SAS SWOT Analysis
Table 113. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Services
Table 114. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. Global Alcohol Addiction Therapeutics Sales by Manufacturer (2018-2019) (K Pcs)
Table 116. Global Alcohol Addiction Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 117. Global Alcohol Addiction Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 118. Global Alcohol Addiction Therapeutics Sales Market Share by Regions (2015-2020)
Table 119. Global Alcohol Addiction Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 120. North America Alcohol Addiction Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 121. North America Alcohol Addiction Therapeutics Sales Market Share by Countries (2015-2020)
Table 122. North America Alcohol Addiction Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 123. North America Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020)
Table 124. Europe Alcohol Addiction Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 125. Europe Alcohol Addiction Therapeutics Sales Market Share by Countries (2015-2020)
Table 126. Europe Alcohol Addiction Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Alcohol Addiction Therapeutics Sales by Regions (2015-2020) (K Pcs)
Table 128. Asia-Pacific Alcohol Addiction Therapeutics Sales Market Share by Regions (2015-2020)
Table 129. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 130. South America Alcohol Addiction Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 131. South America Alcohol Addiction Therapeutics Sales Market Share by Countries (2015-2020)
Table 132. South America Alcohol Addiction Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 133. South America Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020)
Table 134. Middle East & Africa Alcohol Addiction Therapeutics Sales by Countries (2015-2020) (K Pcs)
Table 135. Middle East & Africa Alcohol Addiction Therapeutics Sales Market Share by Countries (2015-2020)
Table 136. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 137. Middle East & Africa Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020)
Table 138. Global Alcohol Addiction Therapeutics Sales by Type (2015-2020) (K Pcs)
Table 139. Global Alcohol Addiction Therapeutics Sales Share by Type (2015-2020)
Table 140. Global Alcohol Addiction Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 141. Global Alcohol Addiction Therapeutics Revenue Share by Type (2015-2020)
Table 142. Global Alcohol Addiction Therapeutics Sales by Application (2015-2020) (K Pcs)
Table 143. Global Alcohol Addiction Therapeutics Sales Share by Application (2015-2020)
Table 144. Global Alcohol Addiction Therapeutics Sales Forecast by Regions (2021-2025) (K Pcs)
Table 145. Global Alcohol Addiction Therapeutics Market Share Forecast by Regions (2021-2025)
Table 146. Global Alcohol Addiction Therapeutics Sales Forecast by Type (2021-2025) (K Pcs)
Table 147. Global Alcohol Addiction Therapeutics Market Share Forecast by Type (2021-2025)
Table 148. Global Alcohol Addiction Therapeutics Sales Forecast by Application (2021-2025)
Table 149. Global Alcohol Addiction Therapeutics Market Share Forecast by Application (2021-2025)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Alcohol Addiction Therapeutics Picture
Figure 2. Global Sales Market Share of Alcohol Addiction Therapeutics by Type in 2019
Figure 3. CM-1212 Picture
Figure 4. CTDP-002 Picture
Figure 5. A-705253 Picture
Figure 6. ABT-436 Picture
Figure 7. ADX-71441 Picture
Figure 8. Others Picture
Figure 9. Alcohol Addiction Therapeutics Sales Market Share by Application in 2018
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Alcohol Addiction Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Alcohol Addiction Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Alcohol Addiction Therapeutics Sales Market Share by Manufacturer in 2019
Figure 34. Global Alcohol Addiction Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Alcohol Addiction Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Alcohol Addiction Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 39. Global Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Alcohol Addiction Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 41. Global Alcohol Addiction Therapeutics Revenue Market Share by Regions in 2018
Figure 42. North America Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. Europe Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. South America Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020)
Figure 47. North America Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Alcohol Addiction Therapeutics Sales Market Share by Countries (2015-2020)
Figure 49. North America Alcohol Addiction Therapeutics Sales Market Share by Countries in 2018
Figure 50. North America Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Alcohol Addiction Therapeutics Revenue Market Share by Countries in 2018
Figure 52. United States Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Canada Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Mexico Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Europe Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Alcohol Addiction Therapeutics Revenue Market Share by Countries in 2019
Figure 58. Germany Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. UK Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. France Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Italy Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Asia-Pacific Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Alcohol Addiction Therapeutics Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Alcohol Addiction Therapeutics Revenue Market Share by Regions 2019
Figure 66. China Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Korea Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. India Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Southeast Asia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. South America Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Alcohol Addiction Therapeutics Sales Market Share by Countries in 2019
Figure 73. South America Alcohol Addiction Therapeutics Revenue Market Share by Countries in 2019
Figure 74. Brazil Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Argentina Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Middle East and Africa Alcohol Addiction Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Egypt Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Turkey Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. South Africa Alcohol Addiction Therapeutics Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Global Alcohol Addiction Therapeutics Sales and Growth Rate (2021-2025) (K Pcs)
Figure 85. Global Alcohol Addiction Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Alcohol Addiction Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 87. Europe Sales Alcohol Addiction Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 88. Asia-Pacific Sales Alcohol Addiction Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 89. South America Sales Alcohol Addiction Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 90. Middle East & Africa Sales Alcohol Addiction Therapeutics Market Forecast (2021-2025) (K Pcs)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel